VolitionRx completes 1-for-20 reverse stock split effective April 28, 2026

VOLITIONRX LTD

Stockholders approved reverse split at special meeting March 31, 2026; Board set ratio at 1:20.
Certificate of Amendment filed with Delaware on April 27, 2026, effective 12:01 a.m. ET April 28, 2026.
Reverse split applies to all outstanding common shares; fractional shares treated per amendment.
Common stock continues trading on NYSE American under ticker VNRX.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

VOLITIONRX LTD: Amended the Certificate of Incorporation to effect a one-for-twenty reverse stock split and describe treatment of fractional shares (effective 2026-04-28).

Change: charter amendment
Effective: 2026-04-28

Exact text from the filing

On April 27, 2026, the Company filed a Certificate of Third Amendment of the Second Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) with the Delaware Secretary of State, which amended Section 6.1 of Article 6 of the Restated Certificate, effective as of 12:01 a.m. ET on April 28, 2026, to (i) give effect to the Reverse Stock Split, and (ii) describe the treatment of any fractional shares of Common Stock upon the effectiveness of the Reverse Stock Split.

View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

VOLITIONRX LTD filing history →

Source: SEC EDGAR

accession 0001477932-26-002619

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.